- Home
- AIBZ vs AVIR Comparison
AIBZ vs AVIR Comparison
Compare AIBZ & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$4.61
Company Overview
Basic Information| Metric | AIBZ | AVIR |
|---|---|---|
| Founded | N/A | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 337.2M | 399.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | AIBZ | AVIR |
|---|---|---|
| Price | $5.24 | $4.61 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 619.9K | 326.4K |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.87 | $2.78 |
| 52 Week High | $9.91 | $6.45 |
Technical Indicators
Market Signals| Indicator | AIBZ | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 30.73 | 41.49 |
| Support Level | N/A | $4.14 |
| Resistance Level | $8.33 | $4.92 |
| Average True Range (ATR) | 0.64 | 0.28 |
| MACD | -0.18 | -0.04 |
| Stochastic Oscillator | 11.19 | 54.43 |
Price Performance
Historical Comparison AIBZ
AVIR
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.